Company intelligence / Profile preview

Johnson & Johnson Enterprise Innovation Inc.

New Brunswick, New Jersey, United States

Ownership: Private
Employees: ~138000
Development stage: Other

Overview

Johnson & Johnson maintains a broad clinical pipeline with ongoing advances in oncology, immunology, neuroscience, and infectious diseases; recent FDA approvals include new therapies for bladder cancer and psoriasis, and it is among the global leaders in therapeutic innovation.

Therapeutic areas: ImmunologyInfectious DiseasesDermatologyCardiovascularOncologyNeurology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapyGene therapyVaccineDeviceBiologic
Industry: Pharma

Partnerships

Collaborations with academic institutions, startups, and major pharma companies worldwide through the innovation centers

Beyond the preview

Go deeper on Johnson & Johnson Enterprise Innovation Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Johnson & Johnson Enterprise Innovation Inc..

Explore the full profile